
Azenta Inc AZTA.OQ reported quarterly adjusted earnings of 5 cents per share for the quarter ended March 31, identical to the same quarter last year. The mean expectation of seven analysts for the quarter was for earnings of 7 cents per share. Wall Street expected results to range from 2 cents to 9 cents per share.
Revenue fell 9.9% to $143.42 million from a year ago; analysts expected $140.91 million.
Azenta Inc's reported EPS for the quarter was a loss of 88 cents.
The company reported a quarterly loss of $40.46 million.
Azenta Inc shares had fallen by 26.6% this quarter and lost 49.2% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had risen by about 22.5% in the last three months.
In the last 30 days, one analyst negatively revised an earnings estimate
RECOMMENDATIONS
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy," 5 "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "hold"
Wall Street's median 12-month price target for Azenta Inc is $45.00
This summary was machine generated from LSEG data May 7 at 01:32 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Mar. 31 2025 | 0.07 | 0.05 | Missed |
Dec. 31 2024 | 0.06 | 0.08 | Beat |
Sep. 30 2024 | 0.10 | 0.18 | Beat |
Jun. 30 2024 | 0.07 | 0.16 | Beat |